PlusVitech has an extensive portfolio of patent families to broadly protect intellectual property, products and research. It consists of 20 international patents including:

  • Patents for personalized cancer treatment
  • Patents for optimized formulation and modes of administration.
  • Patents for companion diagnostic tests to personalize cancer treatment.
  • Patents for the treatment of Coronavirus disease, including SARS-CoV-2 and other similar viruses such as Influenza.
  • Companion diagnostic test patents for personalizing the treatment of disease caused by Coronavirus, including SARS-CoV-2 and other similar viruses such as Influenza.
  • Patents for treatment of other diseases.